Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer: Results From TROPiCS-03.
Dowlati A, Chiang AC, Cervantes A, Babu S, Hamilton E, Wong SF, Tazbirkova A, Sullivan IG, van Marcke C, Italiano A, Patel J, Mekan S, Wu T, Waqar SN. Dowlati A, et al. Among authors: van marcke c. J Thorac Oncol. 2025 Jan 2:S1556-0864(24)02549-8. doi: 10.1016/j.jtho.2024.12.028. Online ahead of print. J Thorac Oncol. 2025. PMID: 39755168 Free article.
Evaluation of trophoblast cell surface antigen-2 (TROP2) protein expression in chemotherapy-resistant and metastatic breast carcinomas.
Van Bockstal MR, Depelsemaeker MC, Daoud L, Fontanges Q, Francois A, Guiot Y, Dekairelle AF, Dubois D, Van Marcke C, Longton E, Duhoux FP, Vernaeve H, Berlière M, Floris G, Galant C. Van Bockstal MR, et al. Among authors: van marcke c. Pathol Res Pract. 2024 Dec;264:155724. doi: 10.1016/j.prp.2024.155724. Epub 2024 Nov 16. Pathol Res Pract. 2024. PMID: 39571340
Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours.
Zago Baltazar R, Claerhout S, Vander Borght S, Spans L, Sciot R, Schöffski P, Hompes D, Sinnaeve F, Wafa H, Renard M, van den Hout MF, Vernemmen A, Libbrecht L, De Roo AK, Mazzeo F, van Marcke C, Deraedt K, Bourgain C, Vanden Bempt I. Zago Baltazar R, et al. Among authors: van marcke c. J Pathol Clin Res. 2024 May;10(3):e12376. doi: 10.1002/2056-4538.12376. J Pathol Clin Res. 2024. PMID: 38738521 Free PMC article.
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers.
Derouane F, Desgres M, Moroni C, Ambroise J, Berlière M, Van Bockstal MR, Galant C, van Marcke C, Vara-Messler M, Hutten SJ, Jonkers J, Mourao L, Scheele CLGJ, Duhoux FP, Corbet C. Derouane F, et al. Among authors: van marcke c. Breast Cancer Res. 2024 Feb 19;26(1):29. doi: 10.1186/s13058-024-01788-8. Breast Cancer Res. 2024. PMID: 38374113 Free PMC article.
A federated learning system for precision oncology in Europe: DigiONE.
Mahon P, Chatzitheofilou I, Dekker A, Fernández X, Hall G, Helland A, Traverso A, Van Marcke C, Vehreschild J, Ciliberto G, Tonon G. Mahon P, et al. Among authors: van marcke c. Nat Med. 2024 Feb;30(2):334-337. doi: 10.1038/s41591-023-02715-8. Nat Med. 2024. PMID: 38195748 No abstract available.
Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor.
Honoré N, van der Elst A, Dietz A, van Marcke C, Helaers R, Mendola A, Dahou H, Marbaix E, Poncin R, Seront E, Schmitz S, Limaye N, Galot R, Machiels JP. Honoré N, et al. Among authors: van marcke c. Eur J Cancer. 2023 Dec;195:113372. doi: 10.1016/j.ejca.2023.113372. Epub 2023 Oct 9. Eur J Cancer. 2023. PMID: 37913682
Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck.
Honoré N, van Marcke C, Galot R, Helaers R, Ambroise J, van Maanen A, Mendola A, Dahou H, Marbaix E, Van Eeckhout P, Longton E, Magremanne M, Schmitz S, Limaye N, Machiels JP. Honoré N, et al. Among authors: van marcke c. Ann Oncol. 2023 Dec;34(12):1175-1186. doi: 10.1016/j.annonc.2023.09.3102. Epub 2023 Oct 23. Ann Oncol. 2023. PMID: 37879442 Free article.
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.
Nakamura Y, Mizuno N, Sunakawa Y, Canon JL, Galsky MD, Hamilton E, Hayashi H, Jerusalem G, Kim ST, Lee KW, Kankeu Fonkoua LA, Monk BJ, Nguyen D, Oh DY, Okines A, O'Malley DM, Pohlmann P, Reck M, Shin SJ, Sudo K, Takahashi S, Van Marcke C, Yu EY, Groisberg R, Ramos J, Tan S, Stinchcombe TE, Bekaii-Saab T. Nakamura Y, et al. Among authors: van marcke c. J Clin Oncol. 2023 Dec 20;41(36):5569-5578. doi: 10.1200/JCO.23.00606. Epub 2023 Sep 26. J Clin Oncol. 2023. PMID: 37751561 Free PMC article. Clinical Trial.
33 results